CDC25B
Basic information
Region (hg38): 20:3786772-3806121
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDC25B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 25 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 3 | 0 |
Variants in CDC25B
This is a list of pathogenic ClinVar variants found in the CDC25B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-3796541-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
20-3796718-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
20-3796718-G-T | not specified | Uncertain significance (Jan 18, 2022) | ||
20-3797653-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
20-3798438-A-G | not specified | Likely benign (Aug 12, 2021) | ||
20-3798450-A-G | not specified | Uncertain significance (Jul 19, 2023) | ||
20-3800463-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
20-3800482-G-A | not specified | Uncertain significance (May 06, 2022) | ||
20-3800767-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
20-3800774-G-A | not specified | Uncertain significance (May 26, 2023) | ||
20-3800799-C-T | Likely benign (Oct 01, 2022) | |||
20-3800803-G-A | not specified | Likely benign (Mar 31, 2022) | ||
20-3800975-G-C | not specified | Uncertain significance (Feb 28, 2023) | ||
20-3801260-A-G | not specified | Uncertain significance (May 06, 2022) | ||
20-3801293-A-C | not specified | Uncertain significance (Dec 19, 2022) | ||
20-3801309-G-A | not specified | Uncertain significance (May 15, 2023) | ||
20-3801311-C-T | not specified | Uncertain significance (May 26, 2024) | ||
20-3801326-C-T | not specified | Uncertain significance (Apr 07, 2023) | ||
20-3801383-T-G | not specified | Uncertain significance (May 09, 2024) | ||
20-3801954-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
20-3801984-G-A | not specified | Uncertain significance (Aug 15, 2023) | ||
20-3801990-C-T | not specified | Uncertain significance (Sep 26, 2022) | ||
20-3802003-A-G | not specified | Uncertain significance (Jan 04, 2022) | ||
20-3802036-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
20-3802062-G-A | not specified | Uncertain significance (Jul 21, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDC25B | protein_coding | protein_coding | ENST00000245960 | 16 | 19185 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.364 | 0.636 | 125729 | 0 | 17 | 125746 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.47 | 291 | 371 | 0.785 | 0.0000243 | 3768 |
Missense in Polyphen | 97 | 150.47 | 0.64465 | 1450 | ||
Synonymous | -0.832 | 156 | 143 | 1.09 | 0.00000911 | 1140 |
Loss of Function | 3.99 | 7 | 30.9 | 0.226 | 0.00000172 | 339 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000188 | 0.000188 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000974 | 0.0000967 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Tyrosine protein phosphatase which functions as a dosage-dependent inducer of mitotic progression. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Directly dephosphorylates CDK1 and stimulates its kinase activity. The three isoforms seem to have a different level of activity. {ECO:0000269|PubMed:17332740}.;
- Pathway
- Cell cycle - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Progesterone-mediated oocyte maturation - Homo sapiens (human);Cell Cycle;Integrated Cancer Pathway;Androgen Receptor Network in Prostate Cancer;Retinoblastoma (RB) in Cancer;MAPK Signaling Pathway;Senescence and Autophagy in Cancer;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer,s disease models;Neurodegenerative Diseases;Disease;Cyclin A:Cdk2-associated events at S phase entry;AndrogenReceptor;Aurora A signaling;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Mitotic G2-G2/M phases;Cell Cycle;Cell Cycle, Mitotic;PLK1 signaling events;FOXM1 transcription factor network;p38 signaling mediated by MAPKAP kinases
(Consensus)
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- loftool
- 0.577
- rvis_EVS
- -1.13
- rvis_percentile_EVS
- 6.48
Haploinsufficiency Scores
- pHI
- 0.608
- hipred
- Y
- hipred_score
- 0.731
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.600
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdc25b
- Phenotype
- digestive/alimentary phenotype; growth/size/body region phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- cdc25b
- Affected structure
- pigment cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;mitotic cell cycle;oocyte maturation;protein phosphorylation;female meiosis I;positive regulation of cell population proliferation;positive regulation of G2/M transition of mitotic cell cycle;positive regulation of cytokinesis;peptidyl-tyrosine dephosphorylation;positive regulation of protein kinase activity;positive regulation of mitotic cell cycle;cell division;positive regulation of G2/MI transition of meiotic cell cycle
- Cellular component
- spindle pole;nucleus;nucleoplasm;cytoplasm;centrosome;cytosol
- Molecular function
- phosphoprotein phosphatase activity;protein tyrosine phosphatase activity;protein binding;protein kinase binding